326 related articles for article (PubMed ID: 24211272)
21. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats.
Kostrubsky VE; Strom SC; Hanson J; Urda E; Rose K; Burliegh J; Zocharski P; Cai H; Sinclair JF; Sahi J
Toxicol Sci; 2003 Nov; 76(1):220-8. PubMed ID: 12944587
[TBL] [Abstract][Full Text] [Related]
23. In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome.
Sakai Y; Iwao T; Susukida T; Nukaga T; Takemura A; Sekine S; Ito K; Matsunaga T
Drug Metab Pharmacokinet; 2019 Aug; 34(4):264-271. PubMed ID: 31285099
[TBL] [Abstract][Full Text] [Related]
24. Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes.
Kang L; Si L; Rao J; Li D; Wu Y; Wu S; Wu M; He S; Zhu W; Wu Y; Xu J; Li G; Huang J
Toxicol In Vitro; 2017 Apr; 40():313-323. PubMed ID: 28161596
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
[TBL] [Abstract][Full Text] [Related]
26. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.
Kotani N; Maeda K; Watanabe T; Hiramatsu M; Gong LK; Bi YA; Takezawa T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2011 Sep; 39(9):1503-10. PubMed ID: 21673128
[TBL] [Abstract][Full Text] [Related]
27. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
[TBL] [Abstract][Full Text] [Related]
28. Hepatic bile acid synthesis and secretion: Comparison of in vitro methods.
de Bruijn VMP; Wang Z; Bakker W; Zheng W; Spee B; Bouwmeester H
Toxicol Lett; 2022 Jul; 365():46-60. PubMed ID: 35724847
[TBL] [Abstract][Full Text] [Related]
29. In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.
Greupink R; Nabuurs SB; Zarzycka B; Verweij V; Monshouwer M; Huisman MT; Russel FG
Toxicol Sci; 2012 Sep; 129(1):35-48. PubMed ID: 22641618
[TBL] [Abstract][Full Text] [Related]
30. Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.
De Bruyn T; Sempels W; Snoeys J; Holmstock N; Chatterjee S; Stieger B; Augustijns P; Hofkens J; Mizuno H; Annaert P
J Pharm Sci; 2014 Jun; 103(6):1872-81. PubMed ID: 24652646
[TBL] [Abstract][Full Text] [Related]
31. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
Jemnitz K; Veres Z; Vereczkey L
Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
[TBL] [Abstract][Full Text] [Related]
32. Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Kemp DC; Zamek-Gliszczynski MJ; Brouwer KL
Toxicol Sci; 2005 Feb; 83(2):207-14. PubMed ID: 15509663
[TBL] [Abstract][Full Text] [Related]
33. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
Jackson JP; Brouwer KR
Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
[TBL] [Abstract][Full Text] [Related]
34. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
[TBL] [Abstract][Full Text] [Related]
35. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
36. Combination lopinavir and ritonavir alter exogenous and endogenous bile acid disposition in sandwich-cultured rat hepatocytes.
Griffin LM; Watkins PB; Perry CH; St Claire RL; Brouwer KL
Drug Metab Dispos; 2013 Jan; 41(1):188-96. PubMed ID: 23091188
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced cholestasis assay in primary hepatocytes.
Van Brantegem P; Chatterjee S; De Bruyn T; Annaert P; Deferm N
MethodsX; 2020; 7():101080. PubMed ID: 33088729
[TBL] [Abstract][Full Text] [Related]
38. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
Mita S; Suzuki H; Akita H; Stieger B; Meier PJ; Hofmann AF; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G159-67. PubMed ID: 15297262
[TBL] [Abstract][Full Text] [Related]
39. Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure.
Kemp DC; Brouwer KL
Toxicol In Vitro; 2004 Dec; 18(6):869-77. PubMed ID: 15465654
[TBL] [Abstract][Full Text] [Related]
40. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
